Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LAUREATE EDUCATION, INC. Director's Dealing 2017

Sep 16, 2017

31075_dirs_2017-09-15_ba47b8ce-9a89-4d3b-b35a-03e702a396e0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: LAUREATE EDUCATION, INC. (LAUR)
CIK: 0000912766
Period of Report: 2017-06-14

Reporting Person: Salnoske Karl D. (Chief Information Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-06-14 Employee Stock Option (right to buy) $17.89 A 3081 Acquired 2027-06-14 Class A Common Stock (3081) Direct
2017-06-14 Employee Stock Option (right to buy) $17.89 A 6024 Acquired 2027-06-14 Class A Common Stock (6024) Direct

Footnotes

F1: Subject to the reporting person's continued employment with the Company, these options will become exercisable in three equal annual installments beginning on December 31, 2017.

F2: The options reported herein were previously reported on the Reporting Person's Form 4 filed on 6/16/2017. That Form 4 omitted the options' expiration date which is being added by this amendment.

F3: On June 14, 2017 the reporting person was granted options to purchase 6,024 shares of Class A Common Stock. Subject to the reporting person's continued employment with the Company (A) one-third of the options will become exercisable if the Company achieves the applicable adjusted EBITDA target in accordance with the Company's 2013 Long-Term Incentive Plan and pursuant to the applicable award agreement (the "Adjusted EBITDA Target") with respect to fiscal year 2018, and (B) two-thirds of the options will become exercisable if the Company achieves the Adjusted EBITDA Target with respect to fiscal year 2019.

F4: Includes 3,081 options that become exercisable in equal annual installments beginning on December 31, 2017, as described in footnote 1 above and 6,024 options that become exercisable if the Company achieves the applicable Adjusted EBITDA Target with respect to fiscal year 2018 and fiscal year 2019, as described in footnote 3.